Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
506U78 (Nelarabine) in Refractory Chronic Lymphocytic Leukemia
NCT00003635Phase 2Completed
- Sponsor
- GSK
- Start
- Jan 1999
- Modality
- Prodrugs/Conditional Activator Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of nelarabine in chronic lymphocytic leukemia (CLL), sponsored by GSK. Started Jan 1999; status: completed.
02
Drugs
nelarabine
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00003635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003635.